Imatinib Withdrawn Phase 1 Trials for Pulmonary Hypertension (PH) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01568645Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease